Countering severe peanut allergies through oral immunotherapy

peanuts
Image credit: ThinkStock

Mom Monica Glover said the family discovered Ellis’ peanut allergy when she was about 3.

…

Glover seized the opportunity to participate in a study on the safety and effectiveness of an experimental treatment that could give her daughter protection against accidental exposure to peanuts. Despite the risk, it was “a gift,” she said, adding that her family hoped their efforts might help “lots of other children.”

The risk paid off: Two-thirds of the kids in the study were able to eat the equivalent of two peanuts without any symptoms after following the months-long experimental treatment regimen, the researchers found.

…

The treatment, which comes in powder-filled capsules, is an oral immunotherapy, and the concept is “treating an allergy by gradually exposing people to the very same thing they’re allergic to,” [researcher Brian] Vickery said. Essentially, the treatment is a peanut powder.

…

“It’s what a lot of families call trying to be ‘bite safe.’ it’s not that you’re curing the allergy; it’s not that you’re going to be able to eat peanut butter sandwiches,” said [pediatrician Scott] Sicherer, who was not involved in the study. “It’s really just to have a better threshold so that if you accidentally ate something that had a little bit of peanut in it, maybe you wouldn’t have a reaction or the reaction wouldn’t be so bad.”

Read full, original post: Experimental treatment helps 2 out of 3 peanut allergy sufferers, study finds

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Supplement Rain Wellness Illustration
Viewpoint: Bedeviled by “toxic inflammation”? How wellness grifters turn this scientific gray zone into a supplement jackpot
Teal Hexagon Technology Icons
4 key ways the Blue Wave will upend science policy
Wave Crest Over Red Cross
Viewpoint: Here are the election-inspired Trump administration healthcare policy reversals expected in the coming months
Aerial Sprayer Over Gradient Fields
Farming, food, and chemicals: Post-midterms, the MAHA alliance between Democrats and MAGA Republicans is bruised but not cowed. What comes next?
Confident Doctor in Clinical Setting
More than 80% of ‘pro-science’ candidates were swept into office. Will they have a policy impact?
Stacked Protest Signs on Concrete Ledge
Voters hate AI data centers, yet they are crucial to establishing a critical technology. So what’s next?
Protect-Womens-Sports-at-the-Capitol
Blue, purple and red states passed or reaffirmed bans on trans females competing in women’s sports
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Democratic Donkey Plowing at Sunset
Viewpoint: Democratic tsunami: As the red tide recedes, here are the most likely shifts in food and agricultural policy
Screenshot-2026-11-05-at-1.20.54-PM
$7.35 billion PFAS settlement: 3M to pay people who blame health problems on ‘forever chemicals’ phased out of firefighting foam for more than 20 years
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.